Vojenska Nemocnice Brno
- Address
- lock Available on a paid plan
Cardiovascular Diseases
At Vojenska Nemocnice Brno, clinical research in cardiovascular diseases focuses on major heart and blood vessel conditions such as acute coronary syndrome, atrial fibrillation, chronic heart failure with reduced ejection fraction, and acute ischemic stroke. These studies are designed to assess new treatment options and compare them with current standard care to better prevent serious events and improve patient outcomes.
- Research on preventing stroke and systemic embolism in atrial fibrillation
- Studies evaluating therapies after acute ischemic stroke or high-risk transient ischemic attack
- Trials aimed at reducing cardiovascular death, heart attack, and other major adverse cardiac events
- Work in chronic heart failure to improve survival and reduce hospitalizations
Overall, this area of research is centered on testing whether newer therapies can offer better protection against stroke, heart attack, and heart failure complications while maintaining safety.
Digestive System Diseases
The site also supports studies in digestive system diseases, with research mainly centered on moderately to severely active ulcerative colitis. These trials look at ways to ease symptoms such as bowel urgency and improve day-to-day disease control for people living with inflammatory bowel disease.
- Evaluation of treatments for ulcerative colitis symptom relief
- Research focused on reducing bowel urgency and improving patient comfort
- Studies assessing whether new therapies can better control intestinal inflammation
This work reflects a broader effort to improve both symptom management and overall quality of life for patients with chronic gastrointestinal inflammation.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 3 of 4 therapeutic areas and 15 of 62 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Top 40 of 62 compounds, ranked by number of trials.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 18 by active trials.
lock +17 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
lock +13 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 634 other sites in Czechia
Therapeutic Area Benchmark — Czechia
Select a therapeutic area to compare against other sites in Czechia.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Czechia
Market Share
Country: Czechia
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Vojenska Nemocnice Brno
lock Showing 1 of 64 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 2, Multi-Center, Platform Study to Evaluate the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics with Multiple Therapies in Participants with Active Crohn’s Disease or Active Ulcerative Colitis (ASCEND-IBD) | Mirador Therapeutics Inc. | Phase II | Recruiting | May 2026 | — |
IMP list
lock Showing 1 of 62 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Duvakitug | 6 | Unknown | 2023-03-17 | 2026-07-22 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.